Expression of CD133 in the cytoplasm is associated with cancer progression and poor prognosis in gastric cancer
出版年份 2013 全文链接
标题
Expression of CD133 in the cytoplasm is associated with cancer progression and poor prognosis in gastric cancer
作者
关键词
Gastric cancer, CD133, Prognosis, HIF-1α
出版物
Gastric Cancer
Volume 17, Issue 1, Pages 97-106
出版商
Springer Nature
发表日期
2013-04-04
DOI
10.1007/s10120-013-0255-9
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cytoplasmic CD133 Expression is a Reliable Prognostic Indicator of Tumor Regression After Neoadjuvant Concurrent Chemoradiotherapy in Patients with Rectal Cancer
- (2012) Shu-Wen Jao et al. ANNALS OF SURGICAL ONCOLOGY
- Interferon-alpha modulates the chemosensitivity of CD133-expressing pancreatic cancer cells to gemcitabine
- (2012) Tomomi Hayashi et al. CANCER SCIENCE
- Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer
- (2012) Yang Jiang et al. Gastric Cancer
- CD133 expression in renal cell carcinoma (RCC) is correlated with nuclear hypoxia-inducing factor 1α (HIF-1α)
- (2012) Chuanyang Sun et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Clinicopathological significance and prognostic value of CD133 expression in triple-negative breast carcinoma
- (2011) Po Zhao et al. CANCER SCIENCE
- CD133 is a marker of gland-forming cells in gastric tumors and Sox17 is involved in its regulation
- (2011) Hiroshi Fukamachi et al. CANCER SCIENCE
- Japanese classification of gastric carcinoma: 3rd English edition
- (2011) Gastric Cancer
- Aberrant expression of CD133 protein correlates with Ki-67 expression and is a prognostic marker in gastric adenocarcinoma
- (2010) Po Zhao et al. BMC CANCER
- The cancer stem cell marker CD133 is a predictor of the effectiveness of S1+ pegylated interferon α-2b therapy against advanced hepatocellular carcinoma
- (2010) Satoru Hagiwara et al. JOURNAL OF GASTROENTEROLOGY
- CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma
- (2010) Mitsuo Shimada et al. JOURNAL OF GASTROENTEROLOGY
- CD133 expression predicts for non-response to chemotherapy in colorectal cancer
- (2010) Chee W Ong et al. MODERN PATHOLOGY
- Frequency and pattern of expression of the stem cell marker CD133 have strong prognostic effect on the surgical outcome of colorectal cancer patients
- (2010) Takahashi ONCOLOGY REPORTS
- Cytoplasmic expression of CD133 is an important risk factor for overall survival in hepatocellular carcinoma
- (2010) Sasaki ONCOLOGY REPORTS
- mTOR Signal and Hypoxia-Inducible Factor-1 Regulate CD133 Expression in Cancer Cells
- (2009) K. Matsumoto et al. CANCER RESEARCH
- Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α
- (2009) A Soeda et al. ONCOGENE
- CD133 expression is an independent prognostic marker for low survival in colorectal cancer
- (2008) D Horst et al. BRITISH JOURNAL OF CANCER
- CD133 expression is correlated with lymph node metastasis and vascular endothelial growth factor-C expression in pancreatic cancer
- (2008) S Maeda et al. BRITISH JOURNAL OF CANCER
- Oct-4 Expression Maintained Cancer Stem-Like Properties in Lung Cancer-Derived CD133-Positive Cells
- (2008) Yu-Chih Chen et al. PLoS One
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started